These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 18594532

  • 1. In vitro sensitivity testing of minimally passaged and uncultured gliomas with TRAIL and/or chemotherapy drugs.
    Ashley DM, Riffkin CD, Lovric MM, Mikeska T, Dobrovic A, Maxwell JA, Friedman HS, Drummond KJ, Kaye AH, Gan HK, Johns TG, Hawkins CJ.
    Br J Cancer; 2008 Jul 22; 99(2):294-304. PubMed ID: 18594532
    [Abstract] [Full Text] [Related]

  • 2. Convection-enhanced delivery of tumor necrosis factor-related apoptosis-inducing ligand with systemic administration of temozolomide prolongs survival in an intracranial glioblastoma xenograft model.
    Saito R, Bringas JR, Panner A, Tamas M, Pieper RO, Berger MS, Bankiewicz KS.
    Cancer Res; 2004 Oct 01; 64(19):6858-62. PubMed ID: 15466173
    [Abstract] [Full Text] [Related]

  • 3. Synergistic interactions of chemotherapeutic drugs and tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand on apoptosis and on regression of breast carcinoma in vivo.
    Singh TR, Shankar S, Chen X, Asim M, Srivastava RK.
    Cancer Res; 2003 Sep 01; 63(17):5390-400. PubMed ID: 14500373
    [Abstract] [Full Text] [Related]

  • 4. Procarbazine, lomustine and vincristine for recurrent high-grade glioma.
    Parasramka S, Talari G, Rosenfeld M, Guo J, Villano JL.
    Cochrane Database Syst Rev; 2017 Jul 26; 7(7):CD011773. PubMed ID: 28744879
    [Abstract] [Full Text] [Related]

  • 5. Targeting multiple pathways in gliomas with stem cell and viral delivered S-TRAIL and Temozolomide.
    Hingtgen S, Ren X, Terwilliger E, Classon M, Weissleder R, Shah K.
    Mol Cancer Ther; 2008 Nov 26; 7(11):3575-85. PubMed ID: 19001440
    [Abstract] [Full Text] [Related]

  • 6. Synergistic induction of apoptosis by the combination of trail and chemotherapy in chemoresistant ovarian cancer cells.
    Cuello M, Ettenberg SA, Nau MM, Lipkowitz S.
    Gynecol Oncol; 2001 Jun 26; 81(3):380-90. PubMed ID: 11371126
    [Abstract] [Full Text] [Related]

  • 7. Increased death receptor 5 expression by chemotherapeutic agents in human gliomas causes synergistic cytotoxicity with tumor necrosis factor-related apoptosis-inducing ligand in vitro and in vivo.
    Nagane M, Pan G, Weddle JJ, Dixit VM, Cavenee WK, Huang HJ.
    Cancer Res; 2000 Feb 15; 60(4):847-53. PubMed ID: 10706092
    [Abstract] [Full Text] [Related]

  • 8. KAAD-cyclopamine augmented TRAIL-mediated apoptosis in malignant glioma cells by modulating the intrinsic and extrinsic apoptotic pathway.
    Siegelin MD, Siegelin Y, Habel A, Rami A, Gaiser T.
    Neurobiol Dis; 2009 May 15; 34(2):259-66. PubMed ID: 19385057
    [Abstract] [Full Text] [Related]

  • 9. NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide.
    Wick W, Hartmann C, Engel C, Stoffels M, Felsberg J, Stockhammer F, Sabel MC, Koeppen S, Ketter R, Meyermann R, Rapp M, Meisner C, Kortmann RD, Pietsch T, Wiestler OD, Ernemann U, Bamberg M, Reifenberger G, von Deimling A, Weller M.
    J Clin Oncol; 2009 Dec 10; 27(35):5874-80. PubMed ID: 19901110
    [Abstract] [Full Text] [Related]

  • 10. Direct stimulation of apoptotic signaling by soluble Apo2l/tumor necrosis factor-related apoptosis-inducing ligand leads to selective killing of glioma cells.
    Pollack IF, Erff M, Ashkenazi A.
    Clin Cancer Res; 2001 May 10; 7(5):1362-9. PubMed ID: 11350907
    [Abstract] [Full Text] [Related]

  • 11. Redox-Active Mn Porphyrin-based Potent SOD Mimic, MnTnBuOE-2-PyP(5+), Enhances Carbenoxolone-Mediated TRAIL-Induced Apoptosis in Glioblastoma Multiforme.
    Yulyana Y, Tovmasyan A, Ho IA, Sia KC, Newman JP, Ng WH, Guo CM, Hui KM, Batinic-Haberle I, Lam PY.
    Stem Cell Rev Rep; 2016 Feb 10; 12(1):140-55. PubMed ID: 26454429
    [Abstract] [Full Text] [Related]

  • 12. Enhanced proapoptotic effects of tumor necrosis factor-related apoptosis-inducing ligand on temozolomide-resistant glioma cells.
    Uzzaman M, Keller G, Germano IM.
    J Neurosurg; 2007 Apr 10; 106(4):646-51. PubMed ID: 17432717
    [Abstract] [Full Text] [Related]

  • 13. Cytotoxicity of TRAIL/anticancer drug combinations in human normal cells.
    Meurette O, Fontaine A, Rebillard A, Le Moigne G, Lamy T, Lagadic-Gossmann D, Dimanche-Boitrel MT.
    Ann N Y Acad Sci; 2006 Dec 10; 1090():209-16. PubMed ID: 17384264
    [Abstract] [Full Text] [Related]

  • 14. TRAIL triggers apoptosis in human malignant glioma cells through extrinsic and intrinsic pathways.
    Song JH, Song DK, Pyrzynska B, Petruk KC, Van Meir EG, Hao C.
    Brain Pathol; 2003 Oct 10; 13(4):539-53. PubMed ID: 14655759
    [Abstract] [Full Text] [Related]

  • 15. Temozolomide sensitizes stem-like cells of glioma spheres to TRAIL-induced apoptosis via upregulation of casitas B-lineage lymphoma (c-Cbl) protein.
    Zhitao J, Long L, Jia L, Yunchao B, Anhua W.
    Tumour Biol; 2015 Dec 10; 36(12):9621-30. PubMed ID: 26142735
    [Abstract] [Full Text] [Related]

  • 16. Linarin sensitizes tumor necrosis factor-related apoptosis (TRAIL)-induced ligand-triggered apoptosis in human glioma cells and in xenograft nude mice.
    Xu ZF, Sun XK, Lan Y, Han C, Zhang YD, Chen G.
    Biomed Pharmacother; 2017 Nov 10; 95():1607-1618. PubMed ID: 28950661
    [Abstract] [Full Text] [Related]

  • 17. Apo2l/Tumor necrosis factor-related apoptosis-inducing ligand prevents breast cancer-induced bone destruction in a mouse model.
    Thai le M, Labrinidis A, Hay S, Liapis V, Bouralexis S, Welldon K, Coventry BJ, Findlay DM, Evdokiou A.
    Cancer Res; 2006 May 15; 66(10):5363-70. PubMed ID: 16707463
    [Abstract] [Full Text] [Related]

  • 18. Induction of death receptor ligand-mediated apoptosis in epithelial ovarian carcinoma: The search for sensitizing agents.
    Moxley KM, Chengedza S, Benbrook DM.
    Gynecol Oncol; 2009 Dec 15; 115(3):438-42. PubMed ID: 19804900
    [Abstract] [Full Text] [Related]

  • 19. Genistein enhances proteasomal degradation of the short isoform of FLIP in malignant glioma cells and thereby augments TRAIL-mediated apoptosis.
    Siegelin MD, Siegelin Y, Habel A, Gaiser T.
    Neurosci Lett; 2009 Apr 03; 453(2):92-7. PubMed ID: 19356600
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of DNA methylation sensitizes glioblastoma for tumor necrosis factor-related apoptosis-inducing ligand-mediated destruction.
    Eramo A, Pallini R, Lotti F, Sette G, Patti M, Bartucci M, Ricci-Vitiani L, Signore M, Stassi G, Larocca LM, Crinò L, Peschle C, De Maria R.
    Cancer Res; 2005 Dec 15; 65(24):11469-77. PubMed ID: 16357155
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.